Sleep Apnea Device Market Report – Global Forecasts to 2023
- July, 2017
- Domain: Healthcare - Medical Devices
- Get Free 10% Customization in this Report
Sleep apnea is a condition in which a person stops breathing for few seconds at night either due to airway blockage or because signal from the brain is not received. In severe conditions, a person stops breathing for more than 10 times in an hour. The American Journal of Epidemiology stated that in 2013, around 26% of the adults aged 30–70 years had some form of sleep apnea, whereby 16% of them had mild sleep apnea and 10% had severe sleep apnea.
Among the various forms of sleep apnea, obstructive sleep apnea (OSA) is the most common type. According to the WHO around 100 million people worldwide have OSA. In the US, OSA is said to affect 1 in 4 men and 1 in 9 women, which totals to 23 million working adults. Center for Disease Control and Prevention has also found that the annual healthcare cost for OSA in the US is $165 billion, which is higher than asthma and obesity. Sleep apnea is resulting in reduced productivity at work and increase in road accidents. The National Highway Traffic Safety Administration has estimated that around 100,000 car accidents, 40,000 injuries, and 1,550 deaths per year are caused due to driver’s fatigue.
The Global Sleep Apnea Devices Market is growing due to factors such as the rising usage of oral appliances, growing awareness of ill effects of untreated sleep apnea in developed countries, technological advances in diagnostics and therapeutic devices, and the increasing number of lifestyle diseases such as diabetes and obesity. However, alternative treatment for sleep apnea, lack of patient compliance, and stringent regulatory approval are some of the factors hampering the market. The market in India, Brazil, and China are also expected to grow at an accelerated pace during the forecast period.
The Global Sleep Apnea Device Market is estimated to witness a CAGR of 7.6% during the forecast period 2017–2023. The Global Sleep Apnea Devices market is analyzed based on three segments, namely device types, end-users, and regions.
Geographically, North America dominated the Global Sleep Apnea Devices Market followed by Europe. These two regions collectively occupy more than 60% of the total market. This was due to the availability of technologically advanced sleep laboratories and the increasing awareness of sleep apnea in these regions. Moreover, high obesity rate and good reimbursement facilities are accelerating the growth of the market. Asia Pacific and RoW are expected to have the highest growth rates during the forecast period. In addition, low awareness of the condition and lack of advanced technology products challenge the Global Sleep Apnea Devices Market growth.
Device Types Analysis:
The diagnosis of sleep apnea is carried out by polysomnography (PSG), home sleep titration, and CPAP titration. The major share of the Global Sleep Apnea Devices Market is occupied by PSG diagnosis, which occupies more than half of the total market. However, the actigraphy devices are the fastest growing devices due to their high sensitivity during the sleep study process.
Post diagnosis, based on the severity, the patient is suggested to use therapeutic devices such as positive airway pressure (PAP) devices or oral appliances. The use of PAP device is the first-line therapy provided, and it occupies nearly half of the market. But nasal obstruction and discomfort of the CPAP masks, and nose and mouth dryness are some of the unmet needs of sleep apnea. Oral appliances are used to address the unmet need of the CPAP devices.
Among the end-users, a large portion of the market is occupied by hospitals and homecare. Technological advancements in the devices are giving rise to user-friendly and compact products. These factors are making the market for home sleep study products to grow at a high rate.
The market leaders for sleep apnea devices are ResMed, Philips Healthcare, Becton Dickinson and Company (CareFusion), and Fisher and Paykel. Other leading players in the market include SomnoMed, Compumedics, Cadwell Laboratories, Imthera Medical, Itamar Medical, and BMC Medical.
Currently, the CPAP devices and consumables are dominating the Global Sleep Apnea Devices market, but a lot of new players are focusing on developing next-generation diagnostic and therapeutic devices to gain future business opportunities. The market is dominated by ResMed, Fisher & Paykel, and Philips Healthcare. Small companies are investing greatly in developing technologically advanced products to gain their market share. In July 2017, Respicardia Inc., raised around $5.1 million for a pivotal trial of its implantable, pacemaker-like device for the treatment of sleep apnea.
The report provides complete details about the usage and adoption rate of sleep apnea devices in various verticals and regions. Thus, the key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in specific verticals to analyze before investing or expanding the business in this market.
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
3.3.1 Chronic Obstructive Pulmonary Disease
3.3.3 Pulmonary Medicine
4 Market Outlook
4.1 Market Definition – Infoholic Research
4.3 Types of Sleep Apnea
4.4 Symptoms of Sleep Apnea
4.5 Technologically Advanced Products
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 Market Characteristics
5.1 Effects of Untreated Sleep Apnea
5.2 Market Dynamics
18.104.22.168 Rising usage of oral appliances
22.214.171.124 Growing awareness of ill effects of untreated sleep apnea in developed countries
126.96.36.199 Technological advances in diagnostics and therapeutic devices
188.8.131.52 Huge pool of undiagnosed sleep apnea patients
184.108.40.206 Emerging markets in developing countries
220.127.116.11 Stringent regulations for approval
18.104.22.168 Alternative treatment for sleep apnea
5.3 DRO – Impact Analysis
5.4 Key Stakeholders
6 Product: Market Size and Analysis
6.2 Diagnostics Devices
6.2.1 Home Sleep Testing
6.2.2 CPAP Titration
6.2.3 Polysomnography (PSG) Devices
6.3 Therapeutic Devices
6.3.1 Oral Appliances
6.3.2 Positive Airway Pressure (PAP) Machines
6.3.3 PAP Consumables
7 End-users: Market Size and Analysis
7.2 Hospitals and Sleep Laboratories
7.3 Home Care
8 Regions: Market Size and Analysis
8.2 North America
8.5 Rest of the World
8.5.3 Middle East
9 Competitive Landscape
10 Vendors Profile
10.1 Becton Dickinson and Company
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 ResMed Inc.
10.2.2 Geographic Presence
10.2.3 Business Focus
10.2.4 SWOT Analysis
10.2.5 Business Strategies
10.3 Fisher & Paykel Healthcare Ltd.
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Philips Healthcare
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
11 Companies to Watch For
11.1 Cadwell Laboratories
11.2 Somnomed Ltd.
11.3 Compumedics Ltd.
11.4 Itamar Medical Ltd.
11.5 BMC Medical Co Ltd.
11.6 ImThera Medical
TABLE 1 SLEEP APNEA DEVICES MARKET REVENUE BY PRODUCTS, 2016–2023 ($MILLION)
TABLE 2 HOME SLEEP TESTING DEVICES MARKET REVENUE BY PRODUCTS, 2016–2023 ($MILLION)
TABLE 3 SLEEP APNEA PREVALENCE RATE
TABLE 4 SLEEP APNEA DEVICES MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION)
TABLE 5 OTHER PROMINENT VENDORS IN THE SLEEP APNEA DEVICES MARKET
TABLE 6 BECTON DICKINSON AND COMPANY: OFFERINGS
TABLE 7 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS
TABLE 8 RESMED INC.: OFFERINGS
TABLE 9 RESMED INC.: RECENT DEVELOPMENTS
TABLE 10 FISHER & PAYKEL HEALTHCARE LTD.: OFFERINGS
TABLE 11 FISHER & PAYKEL HEALTHCARE LTD.: RECENT DEVELOPMENTS
TABLE 12 PHILIPS HEALTHCARE: OFFERINGS
TABLE 13 PHILIPS HEALTHCARE: RECENT DEVELOPMENTS
TABLE 14 CADWELL LABORATORIES, INC.: RECENT DEVELOPMENTS
TABLE 15 SOMNOMED LTD.: RECENT DEVELOPMENTS
TABLE 16 COMPUMEDICS LTD.: RECENT DEVELOPMENTS
TABLE 17 ITAMAR MEDICAL LTD.: RECENT DEVELOPMENTS
TABLE 18 BMC MEDICAL: RECENT DEVELOPMENTS
TABLE 19 IMTHERA MEDICAL: HIGHLIGHTS
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.